Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients

Transplantation Proceedings

Volumn 35, Issue 7, 2003, Pages 2687-2688

  Alavian, S M ^a,b   Hajarizadeh, B ^a   Einollahi, B ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Opposite Iranian Blood T ^*  (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE;

ADULT; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE MARKER; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; LIVER BIOPSY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROCONVERSION; SERODIAGNOSIS; SIDE EFFECT; TREATMENT FAILURE;

EID: 0242552435     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.08.042     Document Type: Conference Paper

References (11)

1. Martin P., Friedman L.S. Kidney Int. 47:1995;1231.
2. Dienstag J.L., Perillo R.P., Schiff E.R., et al. N Engl J Med. 333:1995;1657.
3. Rostaing L., Henry S., Cisterne J.M., et al. Transplantation. 64:1997;1624.
4. Jung Y.O., Lee Y.S., Yang W.S., et al. Transplantation. 66:1998;733.
5. Lewandowska D., Durlik M., Kukula K., et al. Transplant Proc. 32:2000;1369.
6. Kletzmayr J., Watschinger B., Muler C., et al. Transplantation. 70:2000;1404.
7. Han D.J., Kim T.H., Park S.K., et al. Transplantation. 71:2001;387.
8. Fontaine H., Thiers V., Chretien Y., et al. Transplantation. 69:2000;2090.
9. Rostaing L., Modesto A., Baron E., et al. Nephron. 74:1996;512.
10. Tang S., N Ho S.K., Moniri K., et al. Transplantation. 73:2002;148.
11. Walsh K.M., Woodall T., Lamy P., et al. Gut. 49:2001;436.